无症状性炎症标志物升高:初次全膝关节置换术中感染或翻修的风险是否存在?
本研究纳入2010至2022年接受初次全膝关节置换术且术前CRP和ESR升高但无症状的1528例患者,平均随访6.4年。术后1年翻修率为1.6%,5年翻修率为3.8%;术后第1年和第5年假体周围感染率分别为1.7%和2.9%。回归分析未发现任何潜在变量是翻修或假体周围感染的危险因素,结论为无症状性急性期反应物升高不是假体周围感染或无菌性翻修的危险因素。
要点
- 无症状性术前CRP和ESR升高者,术后1年翻修率1.6%,5年翻修率3.8%。
- 术后第1年和第5年假体周围感染率分别为1.7%和2.9%。
- 平均随访6.4年总体生存率96.7%,仅2.2%患者因假体周围感染翻修。
核心结论
- 无症状性急性期反应物升高不是假体周围感染或无菌性翻修的危险因素。
- 平均随访6.4年时总体生存率为96.7%,仅2.2%患者因假体周围感染翻修。
研究设计与样本
- 研究纳入2010至2022年接受初次全膝关节置换术的患者,纳入标准为术前完整生化参数且最低随访12个月。
- 排除第一年内死亡、有炎症性关节炎、自身免疫性疾病、肾脏病变或化脓性关节炎病史的患者。
- 术前48小时内血CRP和ESR升高者接受全面医学检查以排查感染症状,经筛查和咨询后残留的CRP和ESR升高被归类为无症状。
- 排除后共纳入1528例患者,平均年龄66岁(范围35至92岁),平均随访时间6.4年(范围1.6至12.3年)。
主要发现
- 术后1年内翻修率为1.6%,术后前5年翻修率为3.8%。
- 术后第1年和第5年假体周围感染率分别为1.7%和2.9%。
- 回归分析未显示任何潜在变量是翻修或假体周围感染的危险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total knee arthroplasty (TKA) is the treatment of choice for advanced knee osteoarthritis. Long-term studies report high patient satisfaction, while complications such as periprosthetic joint infection (PJI) can be devastating. Knowledge regarding risk factors for PJI is critical to minimize and ideally avoid complications. The purpose of this study was to investigate the risk of PJI and revision in patients who had preoperative asymptomatic high C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels in primary TKAs. METHODS: Patients undergoing primary TKA between 2010 and 2022 were eligible. Inclusion criteria were patients who had preoperative complete biochemical parameters and a minimum follow-up of 12 months. Patients who died during the first year, and those who had a history of inflammatory arthritis, autoimmune disease, renal pathologies, or septic arthritis, were excluded. Patients who had elevated blood CRP and ESR levels taken within 48 hours before surgery underwent a thorough medical examination with a focus on infection symptoms. After screening and consultation, residual elevated CRP and ESR levels were classified as asymptomatic. After exclusions, 1,528 patients were included. The mean age was 66 years (range, 35 to 92), and the mean follow-up time was 6.4 years (range, 1.6 to 12.3). RESULTS: The rate of revision within one year after surgery was 1.6%, whereas the rate of revision in the first 5 years was 3.8%. The PJI rates for the 1st and 5th postoperative years were 1.7 and 2.9%, respectively. Regression analysis did not show any of the potential variables to be a risk factor for revision or PJI. CONCLUSIONS: Asymptomatic elevated acute-phase reactants are not a risk factor for periprosthetic joint infection or aseptic revision. At a mean follow-up of 6.4 years, overall survival was 96.7%, with only 2.2% of patients revised due to a PJI.
引用
- Erdoğan Y, Veizi E, Sezgin BS, et al. Asymptomatic Elevated Inflammatory Markers: Is There a Risk for Infection or Revision in Primary Total Knee Arthroplasty? J Arthroplasty. 2024. PMID: 39437860. doi:10.1016/j.arth.2024.10.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。